MEDS · Wellgistics Health, Inc.
$3.00
-0.55 (-15.49%)
At close · Jul 29
Going-concern doubt
— flagged May 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within twelve months from the date these unaudited condensed consolidated financial statements are issued.”View the 10-Q filed May 19, 2026
Market Cap
$446.13M
Shares
125.67M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.00
Open$3.57
Day$2.97–3.87
52W$2.49–97.50
Avg vol 30d45K
Short int70K · 0.1% float · 4.5d
Short vol41%
DataFeb 2025–Jul 2026
Filing10-Q · May 19
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 19, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 20.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−79%
below
Price vs 50-day avg
−18%
below
RSI (14)
46
neutral
MACD trend
Positive
52-week position
1%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−3%
trailing
6-month return
−82%
trailing
YTD return
−85%
this year
Relative strength
−88%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $14 — 200d above 50d
Institutional flow
Distributing
2 of 13 funds reported for Jun 30 · net -590 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.06% of float · ▼ -33.7% MoM · 4.5 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
13 holders — mid 1-yr range
Squeeze score
27
low risk · 0–100
Fundamentals
Revenue growth
+29%
Y/Y
Gross margin
-28%
contracting
EPS growth
−853%
Y/Y
Balance sheet
$23.4M
net debt
Quant / Vol
risk profile
Volatility
266%
annualized · 1-yr
Max drawdown
−97%
past year
ATR
16.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 19, 2026
Revenue
· Q2-2026
Initiated
$1.78M
prior qtr $1.56M
midpoint +13.8% QoQ
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−79%
Bearish
Price vs 50-day avg
−18%
Bearish
RSI (14)
46
Neutral
MACD trend
Positive
Bullish
52-week position
1%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $4 › 200d $14 — 200d above 50d
Institutional flow
Distributing
2 of 13 funds reported for Jun 30 · net -590 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.06% of float · ▼ -33.7% MoM · 4.5 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
13 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $2
Now $3 · 1%
52-wk high $98
vs 200-day avg -79%
vs 50-day avg -18%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MEDS
this stock
Wellgistics Health, Inc.
|
$446.13M | -85.0% | +0.0% | — | 0.1% |
|
MCK
Mckesson Corp
|
$106.81B | +8.4% | +3.1% | 23.2 | 3.2% |
|
COR
Cencora, Inc.
|
$62.18B | -5.5% | +9.3% | 24.5 | 3.0% |
|
CAH
Cardinal Health Inc
|
$54.71B | +12.0% | -1.9% | — | 2.9% |
|
HSIC
Henry Schein Inc
|
$9.76B | +13.6% | +5.9% | 25.9 | 5.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MEDS | -16.2% | -3.2% | -82.1% | -3.2% | -85.0% |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | -13.8% | -0.9% | -88.4% | -0.9% | -92.0% |